text: Recent studies have reported that << imatinib mesylate >>, a kinase inhibitor that targets the intracellular tyrosine kinase BCR-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the [[ macrophage colony stimulating factor (M-CSF) receptor ]], c-FMS.